 BRYAN, Texas, Sept. 20, 2021 GLOBE NEWSWIRE -- iBio, Inc. NYSEA:IBIO iBio or the Company, a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-based FastPharming Manufacturing System, today announced that the Companys Chairman CEO, Tom Isett, and its CSO, Martin Brenner, DVM, Ph.D., will participate in a fireside chat at the Cantor Virtual Global Healthcare Conference on Monday, September 27, 2021 at 10:00 a.m. Eastern Time. 